✦ LIBER ✦

The novel dual GC-A and GC-B designer natriuretic peptide, cenderitide (CD-NP), enhances the renal actions of furosemide in a model of severe heart failure

✍ Scribed by Lisa C Costello-Boerrigter; Guido Boerrigter; Sarah Mangiafico; Alessandro Cataliotti; John C Burnett

Publisher: BioMed Central
Year: 2011
Tongue: English
Weight: 94 KB
Volume: 11
Category: Article
ISSN: 1471-2210
DOI: 10.1186/1471-2210-11-s1-p17

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bioavailability of intravenous versus su

Bioavailability of intravenous versus subcutaneous administration of the dual GC-A and GC-B designer natriuretic peptide cenderitide in healthy canines

✍ Guido Boerrigter; Lisa C Costello-Boerrigter; Gail J Harty; John C Burnett 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 135 KB

Cenderitide (CD-NP), a novel peptide des

Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure

✍ Lisa C Costello-Boerrigter; John A Schirger; Wayne L Miller; Guido Boerrigter; H 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 135 KB

Costello-Boerrigter et al.: Cenderitide (CD-NP), a novel peptide designed to activate both guanylyl cyclase B and A, activates the second messenger cGMP, suppresses aldosterone, and preserves GFR without reducing blood pressure in a proof-of-concept study in patients with chronic heart failure.

Coadministration of B-type natriuretic p

Coadministration of B-type natriuretic peptide and the vasopressin-2 receptor antagonist tolvaptan: a novel physiologic strategy to enhance water and sodium excretion without adversely affecting renal or neurohumoral function in experimental congestive heart failure

✍ Lisa C Costello-Boerrigter; Guido Boerrigter; Gail J Harty; John C Burnett 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 404 KB

Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime.